Population pharmacokinetic analysis of vancomycin using serum cystatin C as a marker of renal function

Akihiro Tanaka, Tetsuya Aiba, Takashi Otsuka, Katsuya Suemaru, Tatsuya Nishimiya, Tomoyoshi Inoue, Mitsuharu Murase, Yuji Kurosaki, Hiroaki Araki

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

We determined the population pharmacokinetics of vancomycin (VAN) using the glomerular filtration rate (GFR) estimated from the serum cystatin C concentration. We examined the predictive performance of the trough serum VAN concentration for determination of the initial dose by using a new model for the analysis of the population pharmacokinetic parameters. Data for 86 patients were used to estimate the values of the population pharmacokinetic parameters. Analysis with a nonlinear mixed-effects modeling program was done by using a one-compartment model. Data for 78 patients were used to evaluate the predictive performance of the new model for the analysis of population pharmacokinetic parameters. The estimated GFR values determined by using Hoek's formula correlated linearly with VAN clearance (VAN clearance [ml/min] = 0.825 x GFR). The mean volume of distribution was 0.864 (liters/kg). The interindividual variability of VAN clearance was 19.8%. The accuracy of the prediction determined by use of the new model was statistically better than that determined by use of the Japanese nomogram-based model because the 95% confidence interval (-3.45 to -1.38) of the difference in each value of the mean absolute error (-2.41) did not include 0. Use of the serum cystatin C concentration as a marker of renal function for prediction of serum VAN concentrations may be useful.

Original languageEnglish
Pages (from-to)778-782
Number of pages5
JournalAntimicrobial Agents and Chemotherapy
Volume54
Issue number2
DOIs
Publication statusPublished - Feb 2010

Fingerprint

Cystatin C
Vancomycin
Pharmacokinetics
Kidney
Serum
Glomerular Filtration Rate
Population
Nomograms
Confidence Intervals

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Infectious Diseases

Cite this

Population pharmacokinetic analysis of vancomycin using serum cystatin C as a marker of renal function. / Tanaka, Akihiro; Aiba, Tetsuya; Otsuka, Takashi; Suemaru, Katsuya; Nishimiya, Tatsuya; Inoue, Tomoyoshi; Murase, Mitsuharu; Kurosaki, Yuji; Araki, Hiroaki.

In: Antimicrobial Agents and Chemotherapy, Vol. 54, No. 2, 02.2010, p. 778-782.

Research output: Contribution to journalArticle

Tanaka, Akihiro ; Aiba, Tetsuya ; Otsuka, Takashi ; Suemaru, Katsuya ; Nishimiya, Tatsuya ; Inoue, Tomoyoshi ; Murase, Mitsuharu ; Kurosaki, Yuji ; Araki, Hiroaki. / Population pharmacokinetic analysis of vancomycin using serum cystatin C as a marker of renal function. In: Antimicrobial Agents and Chemotherapy. 2010 ; Vol. 54, No. 2. pp. 778-782.
@article{b311160c41af461786e4a5d42528889a,
title = "Population pharmacokinetic analysis of vancomycin using serum cystatin C as a marker of renal function",
abstract = "We determined the population pharmacokinetics of vancomycin (VAN) using the glomerular filtration rate (GFR) estimated from the serum cystatin C concentration. We examined the predictive performance of the trough serum VAN concentration for determination of the initial dose by using a new model for the analysis of the population pharmacokinetic parameters. Data for 86 patients were used to estimate the values of the population pharmacokinetic parameters. Analysis with a nonlinear mixed-effects modeling program was done by using a one-compartment model. Data for 78 patients were used to evaluate the predictive performance of the new model for the analysis of population pharmacokinetic parameters. The estimated GFR values determined by using Hoek's formula correlated linearly with VAN clearance (VAN clearance [ml/min] = 0.825 x GFR). The mean volume of distribution was 0.864 (liters/kg). The interindividual variability of VAN clearance was 19.8{\%}. The accuracy of the prediction determined by use of the new model was statistically better than that determined by use of the Japanese nomogram-based model because the 95{\%} confidence interval (-3.45 to -1.38) of the difference in each value of the mean absolute error (-2.41) did not include 0. Use of the serum cystatin C concentration as a marker of renal function for prediction of serum VAN concentrations may be useful.",
author = "Akihiro Tanaka and Tetsuya Aiba and Takashi Otsuka and Katsuya Suemaru and Tatsuya Nishimiya and Tomoyoshi Inoue and Mitsuharu Murase and Yuji Kurosaki and Hiroaki Araki",
year = "2010",
month = "2",
doi = "10.1128/AAC.00661-09",
language = "English",
volume = "54",
pages = "778--782",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - Population pharmacokinetic analysis of vancomycin using serum cystatin C as a marker of renal function

AU - Tanaka, Akihiro

AU - Aiba, Tetsuya

AU - Otsuka, Takashi

AU - Suemaru, Katsuya

AU - Nishimiya, Tatsuya

AU - Inoue, Tomoyoshi

AU - Murase, Mitsuharu

AU - Kurosaki, Yuji

AU - Araki, Hiroaki

PY - 2010/2

Y1 - 2010/2

N2 - We determined the population pharmacokinetics of vancomycin (VAN) using the glomerular filtration rate (GFR) estimated from the serum cystatin C concentration. We examined the predictive performance of the trough serum VAN concentration for determination of the initial dose by using a new model for the analysis of the population pharmacokinetic parameters. Data for 86 patients were used to estimate the values of the population pharmacokinetic parameters. Analysis with a nonlinear mixed-effects modeling program was done by using a one-compartment model. Data for 78 patients were used to evaluate the predictive performance of the new model for the analysis of population pharmacokinetic parameters. The estimated GFR values determined by using Hoek's formula correlated linearly with VAN clearance (VAN clearance [ml/min] = 0.825 x GFR). The mean volume of distribution was 0.864 (liters/kg). The interindividual variability of VAN clearance was 19.8%. The accuracy of the prediction determined by use of the new model was statistically better than that determined by use of the Japanese nomogram-based model because the 95% confidence interval (-3.45 to -1.38) of the difference in each value of the mean absolute error (-2.41) did not include 0. Use of the serum cystatin C concentration as a marker of renal function for prediction of serum VAN concentrations may be useful.

AB - We determined the population pharmacokinetics of vancomycin (VAN) using the glomerular filtration rate (GFR) estimated from the serum cystatin C concentration. We examined the predictive performance of the trough serum VAN concentration for determination of the initial dose by using a new model for the analysis of the population pharmacokinetic parameters. Data for 86 patients were used to estimate the values of the population pharmacokinetic parameters. Analysis with a nonlinear mixed-effects modeling program was done by using a one-compartment model. Data for 78 patients were used to evaluate the predictive performance of the new model for the analysis of population pharmacokinetic parameters. The estimated GFR values determined by using Hoek's formula correlated linearly with VAN clearance (VAN clearance [ml/min] = 0.825 x GFR). The mean volume of distribution was 0.864 (liters/kg). The interindividual variability of VAN clearance was 19.8%. The accuracy of the prediction determined by use of the new model was statistically better than that determined by use of the Japanese nomogram-based model because the 95% confidence interval (-3.45 to -1.38) of the difference in each value of the mean absolute error (-2.41) did not include 0. Use of the serum cystatin C concentration as a marker of renal function for prediction of serum VAN concentrations may be useful.

UR - http://www.scopus.com/inward/record.url?scp=75749128980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75749128980&partnerID=8YFLogxK

U2 - 10.1128/AAC.00661-09

DO - 10.1128/AAC.00661-09

M3 - Article

C2 - 19933799

AN - SCOPUS:75749128980

VL - 54

SP - 778

EP - 782

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 2

ER -